https://orcid.org/0000-0001-6589-2845
References
- Kohli R, Chaturvedi S. Epidemiology and clinical manifestations of immune thrombocytopenia. Hamostaseologie. 2019;39(3):238–249.
- Neunert C, Noroozi N, Norman G, et al. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost. 2015;13(3):457–464.
- Abrahamson PE, Hall SA, Feudjo-Tepie M, et al. The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review. Eur J Haematol. 2009;83(2):83–89.
- Weycker D, Hanau A, Hatfield M, et al. Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosis. J Med Econ. 2020;23(2):184–192.
- Frederiksen H, Maegbaek ML, Nørgaard M. Twenty-year mortality of adult patients with primary immune thrombocytopenia: a Danish population-based cohort study. Br J Haematol. 2014;166(2):260–267.
- Sailer T, Lechner K, Panzer S, et al. The course of severe autoimmune thrombocytopenia in patients not undergoing splenectomy. Haematologica. 2006;91(8):1041–1045.
- Deutsche Gesellschaft fuer Haematologie und medizinische Onkologie (DHGO). German ITP guidelines 2020. Available from: https://www.onkopedia.com/de/onkopedia/guidelines/immunthrombozytopenie-itp/@@guideline/html/index.html.
- General Haematology Task Force. British committee for standards in haematology. Br J Haematol. 2003;120:574–596.
- Italian National Academy of Medicine. ITP guideline 2001. Available from: http://www.ematologialasapienza.org/Download_file_sezione.asp?Chiave=&ID_sezione=170.
- Nederlandse Vereniging voor Hematologie. Richtlijn Immuun gemedieerde trombocytopenie 2013. Available from: https://hematologienederland.nl/wp-content/uploads/2020/01/ITP_richtlijn_2013__NVvH_.pdf.
- NICE. Treatment summary: Immune thrombocytopenic purpura 2019. Available from: https://bnf.nice.org.uk/treatment-summary/immune-thrombocytopenic-purpura.html.
- Protocole National de Diagnostic et de Soins. Purpura thrombopénique immunologique l’enfant et de l’adulte 2017. Available from: https://www.has-sante.fr/upload/docs/application/pdf/2017-06/dir36/pnds-_purpura_thrombopenique_immunologique.pdf.
- Sociedad Española de Hematología y Hemoterapia. Documento de Consenso. Directrices de diagnóstico, tratamiento y seguimiento de la PTI 2011. Available from: http://www.sehh.es/documentos/40/Guia%20PTI.pdf.
- Khan AM, Mydra H, Nevarez A. Clinical practice updates in the management of immune thrombocytopenia. P T. 2017;42(12):756–763.
- Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829–3866.
- Onisâi M, Vlădăreanu AM, Spînu A, et al. Idiopathic thrombocytopenic purpura (ITP) – new era for an old disease. Rom J Intern Med. 2019;57(4):273–283.
- DRG Research Group. NHS National Tariff Workbook 2019/2020.
- EphRMA. European Pharmaceutical Market Research Association (EphMRA) Code of Conduct 2019. Association EPMR; 2019.
- Ghanima W, Cooper N, Rodeghiero F, et al. Thrombopoietin receptor agonists: ten years later. Haematologica. 2019;104(6):1112–1123.
- Kuter DJ, Macahilig C, Grotzinger KM, et al. Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim. Int J Hematol. 2015;101(3):255–263.
- Gonzalez-Porras JR, Godeau B, Carpenedo M. Switching thrombopoietin receptor agonist treatments in patients with primary immune thrombocytopenia. Ther Adv Hematol. 2019;10. DOI:2040620719837906
- Rodeghiero F. A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP. Br J Haematol. 2018;181(2):183–195.
- Patel VL, Mahévas M, Lee SY, et al. Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia. Blood. 2012;119(25):5989–5995.
- Focosi D, Tuccori M, Maggi F. Progressive multifocal leukoencephalopathy and anti-CD20 monoclonal antibodies: what do we know after 20 years of rituximab. Rev Med Virol. 2019;29(6):e2077. DOI:https://doi.org/10.1002/rmv.2077
- Kistangari G, McCrae KR. Immune thrombocytopenia. Hematol Oncol Clin North Am. 2013;27(3):495–520.